Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFHP3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,687
Award facts
- Contract value 100% obligated
- $26,686.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,686.74 on September 8, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen 2 mL injectable medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals across multiple therapeutic domains. This delivery order for Cosentyx, a biologic immunosuppressant medication used to treat autoimmune conditions, reflects the company's capability to fulfill specialized pharmaceutical needs for military healthcare programs. AmerisourceBergen maintains significant federal contracting relationships and is positioned as a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program, enabling flexible procurement of medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FFHP3?
SPE2DB25FFHP3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FFHP3 worth?
The government has obligated $26,687 on SPE2DB25FFHP3.
Is contract SPE2DB25FFHP3 an order under another contract?
Yes. SPE2DB25FFHP3 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFHP3 competed?
The extent of competition for SPE2DB25FFHP3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award